Roche's New Immunoassay Testing Platform Receives CE Mark

MT Newswires · 2d ago
02:26 AM EDT, 10/27/2026 (MT Newswires) -- Roche (RO.SW) obtained a CE Mark for its cobas smart e immunoanalyser, a new immunoassay testing platform. The new platform offers a planned menu of over 100 high-medical-value assays across critical diseases, with reaction times of 18 minutes or less for more than 90% of tests, the Swiss drugmaker said Tuesday.